Masaaki Sawa

This inventor holds 18 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 7 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Carna Biosciences, Inc., Academia Sinica, Gilead Sciences, Inc.. Active years: 2011-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masaaki Sawa. Retrieved from https://idiyas.com/inventor/masaaki-sawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 18 (Patent Applications = 6)

% Patents Active = 77.8

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 7 (Patent Applications = 3)

Average Co-Inventor Count = 5.3

ph-index = 3

Forward Citations = 39(Granted Patents)

Location History:

Osaka, JP (2012)
Ibaraki, JP (2011 - 2020)
Kobe, JP (2017 - 2024)
Hyogo, JP (2018 - 2024)

Company Filing History:

11 out of 13

Carna Biosciences, Inc.

Gilead Sciences, Inc.

patents

4. 2 out of 264

National Cancer Center

patents

5. 2 out of 14

Sbi Biotech Co., Ltd.

patents

6. 1 out of 10

Crystalgenomics, Inc.

patents

7. 1 out of 102

The Kitasato Institute

patents

where one patent can have more than one assignee

Years Active: 2011-2024

Loading Chart...

Areas of Expertise:

Diacylglycerol Kinase

Oxoisoquinoline

Furanone

Alkynyl Sugar Analogs

Anticancer Agent

Glycoproteomic Probes

Quinazoline

Thiazolidinone

Pyrimidine

Bicyclic Thiazole

Fluorescent Imaging

Antimalarial Activity

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12054490 - Diacylglycerol kinase modulating compounds (2024-08-06),

2. 12037325 - 1,2-diaminobenzimidazole derivative (2024-07-16),

3. 11845723 - Diacylglycerol kinase modulating compounds (2023-12-19),

4. 10793575 - Oxoisoquinoline derivatives (2020-10-06),

5. RE48140 - Furanone derivative (2020-08-03),

6. 10538521 - Pyrimidine derivative having antimalarial activity (2020-01-21),

7. 10317393 - Alkynyl sugar analogs for labeling and visualization of glycoconjugates in cells (2019-06-11),

8. 9974795 - Anticancer agent composition (2018-05-22),

9. RE46815 - Furanone derivative (2018-04-30),

10. 9816981 - Alkynyl sugar analogs for labeling and visualization of glycoconjugates in cells (2017-11-14),

11. 9682961 - Quinazoline derivative (2017-06-20),

12. 9656995 - Triazine derivative (2017-05-23),

13. 9102637 - Bicyclic thiazole compounds (2015-08-11),

14. 8742113 - Furanone derivative (2014-06-03),

15. 8329413 - Glycoproteomic probes for fluorescent imaging of fucosylated glycans in vivo (2012-12-11),

Title: The Innovative Journey of Inventor Masaaki Sawa

Introduction: Masaaki Sawa, a pioneering inventor hailing from Ibaraki, Japan, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents: Masaaki Sawa holds several patents in the field of robotics and artificial intelligence, with his most recent patent focusing on a revolutionary humanoid robot designed to assist in healthcare settings.

Career Highlights: Throughout his illustrious career, Masaaki Sawa has been at the forefront of technological advancements, working with leading research institutions and universities to develop cutting-edge solutions for complex challenges.

Collaborations: Masaaki Sawa has collaborated with top companies in the tech industry, including renowned robotics firms and AI startups, to bring his innovative ideas to life and make a lasting impact on the field of technology.

Conclusion: In conclusion, Masaaki Sawa's relentless pursuit of innovation and his passion for pushing the boundaries of what is possible have solidified his position as a visionary inventor in the realm of robotics and artificial intelligence.

Profile summary based on public USPTO records.